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Lack of Effect of Drinking Water Barium
on Cardiovascular Risk Factors
by Robert G. Wones,* Betsy L. Stadler,* and
Lawrence A. Frohman*
Higher cardiovascular mortality has been associated in a single epidemiological study with higher
levelsofbariumindrinkingwater. Thepurpose ofthisstudywastodetermine whetherdrinkingwater
bariumatlevelsfoundinsomeU.S. communities alterstheknownriskfactorsforcardiovasculardisease.
Elevenhealthy mencompleteda 10-week dose-response protocolinwhichdietwascontrolled (600 mg
cholesterol; 40% fat, 40% carbohydrate, 20% protein; sodiumandpotassiumcontrolledatthesubject's
pre-protocol estimated intake). Other aspects ofthe subjects' lifestyles known to affect cardiac risk
factors were controlled, andthebarium content (asbariumchloride) ofthedrinking water (1.5 L/day)
was varied from 0 (first 2 weeks), to 5 ppm (next 4 weeks), to 10 ppm (last 4 weeks). Multiple blood
andurinesamples, morningandeveningbloodpressure measurements, and48-hrelectrocardiographic
monitoringwereperformedateachdose ofbarium. Therewerenochangesinmorningoreveningsystolic
ordiastolicbloodpressures, plasmacholesterolorlipoproteinorapolipoproteinlevels, serumpotassium
orglucose levels, orurinecatecholamine levels. There were noarrythmiasrelated tobariumexposure
detected oncontinuouselectrocardiographicmonitoring. Atrendwasseentowardincreasedtotalserum
calciumlevels with exposure tobarium, whichwasofborderline statistical significanceand ofdoubt-
ful clinical significance. In summary, drinking water barium at levels of 5 and 10 ppm did not appear
to affect any of the known modifiable cardiovascular risk factors.
Introduction
The current interim drinking water standards forthe
United States require that water systems have no more
than 1 ppm (ppm = part per million = mg/L)barium in
thedrinkingwatertheysupply. Thisisnot aproblemfor
the many areas ofthe country that draw theirdrinking
water from streams and lakes. However, many ground-
waters include concentrations ofbarium higher than 1
ppm, and systems that use these groundwater sources
may not meet the standards. Communities facing this
problem exist in Illinois, Thxas, Georgia, New Mexico,
Kentucky, and Pennsylvania (1). In these areas, drink-
ingwatermaycontain asmuch as 10ppmofbarium, and
loweringthe barium content is difficult. Therefore it is
important toknowwhether ornottheinterimdrinking
waterstandardof1 ppmis necessarytoprotecthumans
against adverse health effects.
There are at least two reasons to believe that the in-
terim drinking water standard of 1 ppmbarium maybe
unnecessarily low (2). First, the standard was derived
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from inhalation data for barium because of the lack of
dataregardinghumantoxicityatlowlevelsofexposure
by ingestion (3). There are significant differences be-
tween inhaling barium and ingesting barium in drink-
ingwater, andtheremaybenorelationshipbetweenthe
toxicityofinhaledbarium and that ofingestedbarium.
Also, the interim standard was developed using an
assumption of90% absorptionofbariumfrom drinking
water(3). Morerecentworksuggeststhatonly5to20%
ofbarium is absorbed from drinkingwater(4-7). Thus,
itmaybereasonabletore-evaluatethebariumdrinking
water standard of 1 ppm.
The Safe Drinking Water Committee of the National
Research Council ofthe National Academy of Sciences
has recommended that the barium standard be raised
(2). Their 1982 analysis, which assumed a maximum
gastrointestinalabsorptionofbariumof20%, suggested
thatalevelof9.4ppmissafe. Theirrecommendedstan-
dard is 4.7 ppm, which incorporates a safety factor of
two. Therefore, weraisethequestions: Isthisrecommen-
dationreasonable? Whatdataareavailabletoassessthe
health effects of drinking water barium?
Threecategoriesofhealtheffectsdataexistfordrink-
ingwaterbarium. Thefirsttypeishumanepidemiologi-
caldata. Atlowconcentrations(lessthan 1ppm), several
epidemiologicalstudieshave shown aninverse correla-
tionbetweendrinkingwaterbariumcontentandcardio-
vascularmortality(8,9). Attheselowerconcentrations,WONES, STADLER, AND FROHMAN
cardiovasculardeathratesdecreaseasbariumincreases.
Ofcourse, water higher in barium tends to be higher in
both calcium and magnesium (harder), so this finding
maybeconfoundedbyotherfactors. Incontrast, higher
concentrations of barium (greater than 1 ppm), have
beenassociatedwithhighercardiovascularmortalityin
one epidemiological study (10). An area of northern Il-
linois that has high drinking water barium concentra-
tions(7-10 ppm)wascompared withanearbyareathat
has low drinking water barium concentrations, and a
higher cardiovascular death rate in the area with high
barium concentrations wasfound. Anotherstudyinthe
sameareasfoundnodifferences inbloodpressurelevels
(11). These epidemiological studieshave beencriticized
forfailure tocontrolforrace, watersoftening, andother
factors that are known to potentially affect the results.
Thus, the epidemiological data on the health effects of
drinking water barium are inconclusive at this time.
Barium may have no effect, a beneficial effect, or an
adverse effect on cardiovascular death rates.
Thesecondtypeofdataapplicabletothisissueisacute
human toxicity experiences from accidental overdoses
thoughitisdifficulttoapplyoverdosedatatothechron-
ic, low-dosesituation. Inlargeoverdoses, bariumcauses
cardiac arrythmias, hypokalemia, and hypertension as
wellasothereffects(1,12). Toxic doses havebeengiven
also to animals andsimilarfindings havebeen reported
(13). Doses necessary to achieve these toxic effects in
humansare approximately 500ppm, assuminga 1-Lin-
gestion (1).
Thethirdtypeofdataisderivedfromchroniclow-dose
administration of barium in drinking water to animals
(14-16). Ingeneral, chronic exposure ofratstorelative-
lyhighlevelsofbariumindrinkingwaterappearstohave
no deleterious effects. Minor changes in cholesterol,
glucose, and urine protein were observed in one study
(15), but there was no effect on mortality, growth, or
other factors. Hypertension was seen at very high ex-
posures in another study (16). Thus, chronic exposure
ofanimalstobariumatthesamelevelstowhichhumans
are exposed disclosed few apparent significant effects.
Overall, the data on the health effects of drinking
water barium are incomplete, mixed, and inadequate.
The purpose of this study, therefore, was to explore in
humans the health-related effects, particularly those
related tocardiovascular riskfactors, ofdrinkingwater
barium.
Patients and Methods
Elevenhealthymalevolunteerswerestudied usingthe
protocol shown in Figure 1. The subjects' ages ranged
from 27 to 61 years (mean 39.5 years; median 41 years
ofage). Fourwereblackandsevenwere white. None of
thesubjectshadhypertension, diabetes, orcardiovascu-
lardiseaseofanykind. Theywereonnomedicationsdur-
ingthe course ofthe study. Allprovided informed con-
sent, theprotocolwasapprovedbytheUniversityofCin-
cinnati Institutional Review Board, and the study was
Week 0 1 2 3 4 5 6 7 8 9 10
Drinking water 1.5 L/day 1.5 L/day 1.5 L/day
distilled 5 ppm barium 10 ppm barium
Diet Basal Basal Basal
x x x
Lab studies SX SX SX
S UX
S UX
S UX xxU mx x ux x ux
EKG monitoring ______-__
FIGURE 1. Study protocol. X, Lipid profile (total cholesterol, HDL-
cholesterol, LDL-cholesterol, triglycerides); apolipoproteins Al,
A2, B; renal profile (Na, K, Cl, C02, BUN, creatinine, glucose);
calcium, albumin. U, 24-hrurine forNa, K, VMA/metanephrines.
S, CBC, urinalysis, hepatic/bone profiles. #, resting 12-lead EKG;
24-hr Holter monitor.
performed in the University of Cincinnati General
Clinical Research Center (GCRC).
During the 10-week protocol, all food and beverages
wereprovidedbystudystaff, foodwasconsumedinthe
GCRC, and subjects were instructed not to eat or drink
anythingotherthanwhatwasprovided. Duringthefirst
2 weeks, the drinking water (1.5 L/day) consisted only
ofdistilled water. Duringthenext4weeks, thedrinking
water (1.5 L/day) contained 5 ppm barium in the form
ofbariumchloride. Duringthelast4weeksofthestudy,
thedrinkingwater(1.5 L/day)contained 10ppmbarium.
Subjects were permitted to drink additional distilled
water after consuming the mandatory 1.5 L of study
water if they so desired.
Alldrinkingwaterwasdistilled and charcoal-filtered
to remove trace impurities. A concentrated solution of
barium chloride, prepared weekly, was diluted with
distilledwatertotheappropriateconcentrationonadai-
ly basis. An aliquot of drinking water prepared in this
way was tested daily for barium content, and these
measures confirmed that the subjects' drinking water
contained the specified barium concentrations. Strict
recordingofmandatorywaterintakeaswellasoptional
water intake was maintained throughout the protocol.
Thesubjects' dietswerestrictlycontrolledduringthe
course ofthe study. The dietsconsisted of20% protein,
40% fat, and 40% carbohydrate. The polyunsaturated:
saturated ratio forfats was 0.4. The diet contained 600
mgoftotalcholesteroldaily. Sodiumandpotassiumwere
strictlycontrolledthroughoutthe 10weeksatlevelscon-
sistentwiththesubject'spre-protocolintake. Thus, this
diet was fairly typical of the American diet, though it
wasslightlymoreatherogenic(higherincholesteroland
saturatedfat)thancurrentdietarypractices. Sodiumand
potassiumintakewereregulated atusuallevelsforeach
subject. The barium content ofthe diet was unknown.
However, the barium content of a typical hospital diet
has been measured previously elsewhere and found to
be about 0.75 mg/day(17). Thus, the amount ofbarium
in the diet probably was small relative to the amount
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ingested inthe drinkingwaterduringthestudyperiods
(7.5 mgand 15 mg/day, respectively, for the 5-ppm and
10-ppm periods).
Otherfactorsknowntoaffectcardiovascularrisk were
controlled as well. Subjects were asked to perform the
same amount of exercise during the entire 10 weeks of
protocol. They were allowed to smoke, but ifthey were
smokers they were instructed to smoke consistently
throughout theprotocol, andthis wasmonitoredby pa-
tientdiary on adailybasis. Subjects wereinstructed not
to consume anyalcohol. Theycontinued theirusualdaily
working schedule and were allowed to sleep at home
overnight.
Multiple data items were collected as illustrated in
Figure 1. Blood was collected at admission and peri-
odicallythroughouttheprotocol. However, themainend
points were four consecutive daily samples at the end
ofeach ofthe three study periods (0, 5, 10 ppm). Blood
was obtained at this time for plasma total cholesterol,
triglycerides, and HDLcholesterol; apolipoproteins Al,
A2, and B; serum potassium and glucose; and serum
calcium and albumin. Two 24-hr urine collections were
performed attheend ofeachstudyperiod for measure-
mentofsodium andpotassiumcontentand vanillyman-
delic acid (VMA) and total metanephrines. LDL choles-
terol was calculated as total cholesterol minus HDL
cholesterol minus triglycerides/5. Corrected (for
albumin)calciumlevels werecalculated astotalcalcium
minus albumin plus 4.
No attempt was made to determine barium levels in
serum orto measuretheabsorptionofthebariuminthe
drinking water. Because barium is cleared rapidly from
serumviadepositioninbone(18,19), attemptsinthepast
to measure serum levels chemically after oral intake in
animals have been unsuccessful (14). Such measure-
ments require radioisotope methods that were outside
the scope of this study.
Electrocardiograms and 24-hr continuous electro-
cardiographicmonitoring wereperformed on2 consecu-
tive days at the end ofeachstudy period. The principal
end points from the electrocardiographic monitoring
werethestandard cardiaccycleintervals(PR, QRS, and
QTintervals)and anyarrhythmiasdetectedbythe24-hr
monitoring including indices of ventricular irritability
such as premature ventricular contractions.
Inadditiontotheprimaryendpointsdescribedabove,
safety testsincludingcompleteblood counts, urinalyses,
and liverfunction tests were performed periodically as
shown in Figure 1.
Thelipid testsdescribed above wereperformed using
Centers for Disease Control (CDC) standardized meth-
odology (20,21). The apolipoprotein studies were also
performed using recognized methods in the same
laboratory (22,23). Theremainingblood tests were per-
formedbystandardprocedures intheUniversityofCin-
cinnati Hospital laboratory. Electrocardiographic
measurements and interpretations were provided by
studystaffandhospitalcardiologists who were unaware
of the study design or intent.
Laboratory test results were analyzed by a two-way
analysisofvariancetechniqueusingsubjectanddoseby
standard SAS procedures. Each cell in the two-way
ANOVA consisted of the mean of the four (or two)
samples obtained at the end ofeach study period. The
EKG intervals were analyzed in a similar fashion. The
numberofprematureatrialandventricularcontractions
were analyzed similarly, although the other findings of
the 24-hr electrocardiographic monitoring required
qualitative interpretation.
Results
Results of the principal outcome variables measured
in this study are shown in Thble 1. With exposure to
barium there was no change in eithermorning or even-
ingsystolic ordiastolicblood pressures. Similarily, there
was no change in total cholesterol, triglycerides, HDL
cholesterol, orcalculatedLDLcholesterol. Apolipopro-
teinsAl, A2, and B were unchanged. Serum potassium
andglucose did notchangethroughtheprotocol. Urine
metanephrinesalsodidnotchangeandurineVMAshow-
ed no consistent change with increasing barium dose
suggesting that the observed difference at 5 ppm was
because of chance.
There was a trend towards increased total serum
calcium between0 and 5 ppm thatpersisted at 10 ppm.
Sinceabouthalfofthetotalcalciuminthebloodisbound
toprotein, primarilyalbumin, wefurtherevaluatedthis
borderline finding by calculating a corrected calcium
levelthatisnormalizedfordifferencesinalbuminlevel.
Thiscalculation revealed anapparentstatisticallysignifi-
Table 1. Summary data.
Study period
ANOVA
Outcome variable 0 ppm 5 ppm 10 ppm p value
AM systolic BP, mm Hg 117 117 117 0.94
AM diastolic BP, mm Hg 77 76 75 0.28
PMsystolic BP, mm Hg 120 117 118 0.35
PMdiastolic BP, mm Hg 77 76 76 0.42
Total cholesterol, mg/dL 193 195 192 0.79
Triglycerides, mg/dL 80 87 80 0.07
LDL-C, mg/dL 127 128 126 0.73
HDL-C, mg/dL 50 49 51 0.32
LDL:HDL ratio 2.80 2.86 2.67 0.10
Apo B, mg/dL 114 121 119 0.27
ApoAl, mg/dL 130 128 127 0.58
Apo A2, mg/dL 46 45 44 0.42
Potassium, mEq/L 4.12 4.18 4.21 0.17
Glucose, mg/dL 89 90 88 0.46
Calcium, mg/dL 9.11 9.23 9.23 0.08
Albumin, gm/dL 4.25 4.20 4.19 0.15
Corrected calciuma 8.86 9.03 9.01 0.01
Urine metanephrines, Ag/mg Cr 0.21 0.22 0.26 0.39
Urine VMA, Ag/mg Cr 2.48 1.96 2.44 0.02
Heart rate, beats/min 71 71 71 0.99
PR interval, sec 0.16 0.17 0.17 0.08
QRS interval, sec 0.10 0.10 0.10 0.63
QT interval, sec 0.37 0.37 0.37 0.79
PAC's, per hr 0.9 7.3 1.3 0.16
PVC's, per hr 0.26 0.19 0.05 0.46
aCorrected calcium = total calcium - albumin +4.0
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cant increase in total calcium, which was attributed to
aslightdecrease inserum albuminduringthe course of
thestudy. Theabsolutemagnitude ofthischangeisquite
small and would not be expected to be clinically
important.
The cardiac cycle intervals by electrocardiography
wereunchangedthroughoutthestudy. Inparticular, the
QTintervalandtheQTintervalcorrected forheart rate
(not shown) did not shorten with exposure to barium.
Increases in serum calciumtypicallyshortentheQTin-
terval, andthelackofanyshorteningsupports ourbelief
thattheborderline increaseincalciumwasnotclinical-
ly significant.
Therewerenosignificantarrhythmiasnotedwhenthe
subjectswereexposedtobarium. Therewasnoincrease
in ventricular irritability, as manifested by the number
of premature ventricular contractions during prolong-
ed monitoring. Similarily, there were no apparent con-
ductionproblems. Thenumberofpremature atrialcon-
tractions did increase somewhat during the 5 ppm
bariumexposureperiod, butthiswasnotstatistically or
clinicallysignificant. Onesubjecthadseveralbriefruns
ofventriculartachycardiaduringthemonitoringatthe
end ofthe distilled waterperiod. Ventriculartachycar-
diaisapotentially seriousarrythmia, thoughwhenitis
foundinsubjectswithoutotherapparentheartdisease,
it is not usually of major consequence. No subsequent
ventricular tachycardia was noted in this subject dur-
ing either of the barium periods.
Discussion
Inthisstudy, theexposureof11 healthymentobarium
indrinkingwateratconcentrations of5and 10ppmdid
not result in any apparent changes in modifiable car-
diovascular risk factors. Specifically, there was no in-
creaseinbloodpressure, cholesterolortriglyceridelevels,
orglucose orpotassiumlevels. Therewasnodetectable
effectofbariumoncatecholaminemetabolismthatcould
resultinhighbloodpressureorseriousarrhythmias. Fur-
thermore, directmonitoringofheartrhythm showed no
impact on several indices of cardiac irritability and ar-
rhythmia potential.
There was a trend toward slightly increased total
calciumintheblood. Thisincrease intotalcalciumcould
not be explained by increases in blood protein levels.
When the total calcium was corrected for changes in
albumin levels, the trend toward the increase became
statisticallysignificant. However, themagnitude ofthe
change was very small and could not be implicated as
a factor increasing cardiovascular risk. It should be
noted, also, that multiple comparisons were made by
design in this study. Thus, the chances of showing a
statistically significant change in asinglevariable atan
alphalevelof0.05aregreaterthan50% bychancealone.
Moreover, workinanimalshasnotshownanychangein
serum calcium with exposure to barium(14). Thus, this
apparentchangeintotalcalciumshouldbeviewedonly
asanisolatedfindingworthyoffutureresearchspecific-
ally designed to confirm whether or not a change in
calciummetabolismoccursinpeopleoranimalsconsum-
ing barium in their drinking water.
A numberoflimitations ofthis study should be men-
tioned. First, because we studied only 11 healthy men,
itispossiblethatatrueeffectwasunrecognizedbecause
ofthesmallnumbersofsubjectsorbecausethesubjects
werehealthy. However, inasimilarstudyinvolvingdrink-
ingwaterchlorineandcholesterolmetabolism, achange
of only 3% in total cholesterol level was shown to be
statistically highlysignificant(24). Thedesignofthistrial
makeseachsubjecthisowncontrol, thusmakingitpossi-
ble to detect very small changes in outcome variables.
Obviously, itispossiblethatpeoplewithcardiovascular
disease orcardiovascularriskfactorsmightbe affected
differently by barium than healthy men would be. We
cannotexcludethispossibilitythoughthisstudyprovides
no data to support it.
Asecondpotentiallimitationistherelativelybriefex-
posure interval. The baseline period was only 2 weeks
longbecauseallofthesubjectswereconsumingCincin-
natidrinkingwaterwhich, becauseitisdrawnfromthe
OhioRiver, isverylowinbarium. Also, therewasnoneed
for a significant washout period. The study intervals
were also relatively brief(4 weeks), though most drugs
anddietarychangesthataffectcardiovascular riskfac-
torsmanifestthoseeffectswithinamonthofinitiation.
Evenso, wecannotexcludethepossibilitythatexposure
to barium for years would produce effects, whereas
short-term exposure did not.
A third potential limitation is the lack of data on ab-
sorption ofbarium or serum levels in these subjects, as
discussedearlier. However, thereisnoreasontosuspect
that their absorption or serum levels would be any dif-
ferent than that ofother adults exposed chronically to
drinking water barium in this country.
This study contributes to the aforementioned litera-
tureonthehealtheffectsofbariuminthefollowingways.
First, it appears that toxic effects of ingested barium,
suchashypertensionandhypokalemiaobservedathigh
doses, are not seen at the lower concentrations, which
may be found in drinking water supplied to humans.
Because toxic effects of overdoses of barium are seen
acutely, ananalogous effectatlowerdosesshould have
appeared in this study if it truly existed. Second, this
studyconfirmsthegenerallynegativestudiesperform-
edinrats. Naturally, thisstudydoesnotprovideanymor-
talitydatatosupportorrefutetheepidemiologicaldata
on this subject, though it suggests that any impact of
drinking water barium on cardiovascular disease does
notoccurthroughtheknownmodifiablecardiovascular
riskfactors. Thisprotocolstudieddrinkingwaterbarium
concentrations of5 and 10 ppm. The negative findings
support the findings of the Safe Drinking Water Com-
mittee at the National Research Council that drinking
water barium is probably safe forhuman consumption
up to a concentration of 9.4 ppm and that raising the
standardto4.7ppm(withasafetyfactorof2)mightbe
reasonable.
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In summary, this study, performed under carefully
defined experimental conditions, did not show any sig-
nificantimpactofdrinkingwaterbariumat5and 10ppm
on the known modifiable cardiovascular risk factors. A
trend towards increased serum calcium was observed
though this finding needs to be confirmed by other
studies specifically designed for that purpose.
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